Methods： In this 26-week, multicentre, open-label, parallel-group trial, 320 subjects with Type 1 diabetes received either insulin detemir twice daily or insulin glargine once daily. each in combination with premeal insulin aspart.
Methods： In this 26-week, multicentre, open-label, parallel-group trial, 320 subjects with Type 1 diabetes received either insulin detemir twice daily or insulin glargine once daily. each in combination with premeal insulin aspart.
方法：在一项26周、多中心、非盲、平行对照试验中，320例糖尿病患者使用每日2次地特胰岛素或每日1次甘精胰岛素治疗，每组联合餐前诺和锐。